Systemic Review: Real-World Data for Healthcare Research in China
Despite the emergence of several new sources of real-world evidence for healthcare in China, little has been done to evaluate [...]
China National Insurance System and Pharma Reach Pricing Agreement
Pharma and the Chinese government have reached an agreement resulting in price cuts averaging over 60% for Chinese citizens. The [...]
Harnessing the Power of RWD in China
In 2018, China made the cultivation of healthcare big data a national priority. Such data represent a tremendous opportunity for [...]
How Did Pharmaceutical Policy Reform Change the Healthcare Landscape in China?
China’s pharmaceutical market is second only to the United States valued at $137 billion (USD). Fueling Growth has been fueled [...]
Advertisement
